External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6600759.pdf
Reference19 articles.
1. de Wit R, Roberts JT, Wilkinson P, de Mulder PHM, Mead GM, Fosså SD, Cook P, de Prijck L, Stenning S, Collette L (2001) Final analysis demonstrating the equivalence of 3 BEP vs. 4 cycles and the 5 day schedule vs. 3 days per cycle in good prognosis germ cell cancer. An EORTC/MRC phase III study. J Clin Oncol 19: 1629–1640
2. Donohue JP, Rowland RG, Kopecky K, Steidle CP, Geier G, Ney KG, Einhorn L, Williams S, Loehrer P (1987) Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 137: 1176–1179
3. Fosså SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE (1992) Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?. J Clin Oncol 10: 569–573
4. Gelderman WA, Koops HS, Sleijfer DT, Oosterhuis JW, Oldhoff J (1986) Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors. Cancer 58: 1418–1421
5. Gels ME, Nijboer AP, Hoekstra HJ, Sleijfer DT, Molenaar WM, Plukker JT, Droste JH, Schraffordt Koops H (1997) Complications of the post-chemotherapy resection of retroperitoneal residual tumour mass in patients with non-seminomatous testicular germ cell tumours. Br J Urol 79: 263–268
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer;Journal of Clinical Oncology;2023-12-01
2. Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients;BJU International;2023-05-20
3. A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours;Frontiers in Oncology;2022-08-17
4. Refinement of the Management of Germ Cell Cancer: What’s Next?;Journal of Clinical Oncology;2019-11-20
5. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors;World Journal of Urology;2016-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3